Samsung Acquires NeuroLogica

By Admin
Share
Follow @HealthCareG Samsung plans expansion into the medical device sector Computer giant acquires NeuroLogica as part of its expansion Samsung has...

Samsung has announced its acquisition of medical imaging company NeuroLogica. The technology giant plans to build a leading medical technology business and “the acquisition of NeuroLogica is another important step in the expansion of Samsung’s medical imaging business,” said Tod Pike, Senior VP at Samsung’s Enterprise Division.

The press statement outlines Samsung’s plans to expand its medical division, however terms of the deal itself were not disclosed.  

NeuroLogica was founded in 2004 in Boston and it known for its portable computed tomography (CT) scanners, including BodyTom and CereTom.

Samsung has outlined ambitious plans to become one of the world’s leading medical equipment suppliers by 2020.

In November 2012, Samsung Electronics America, a subsidiary of Samsung, announced the addition of Samsung Health & Medical Equipment, which merged employees from Samsung Medison America, its ultrasound machine manufacturer, into its Enterprise Business Division.

Samsung had acquired Medison in 2010 and its medical technology business as a “key element in Samsung’s 2020 vision to explore new areas of growth,” said the company at the time.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma